Ignite Creation Date:
2024-05-06 @ 1:49 PM
Last Modification Date:
2024-10-26 @ 1:20 PM
Study NCT ID:
NCT04134390
Status:
COMPLETED
Last Update Posted:
2024-01-09
First Post:
2019-10-15
Brief Title:
Study of Cabozantinib Efficacy Safety and Tolerability in Metastatic Renal Carcinoma in Aged Fragile Patients CABOMAYOR Study
Sponsor:
Spanish Oncology Genito-Urinary Group
Organization:
Spanish Oncology Genito-Urinary Group
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-11-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-11-22
Completion Date Type:
ACTUAL
First Submit Date:
2019-10-15
First Submit QC Date:
October 17 2019
Study First Post Date:
2019-10-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-08
Last Update Post Date:
2024-01-09
Last Update Post Date Type:
ACTUAL